Phase 3 Outcome Management Model

I selected to do Phase three of the Outcomes Management Model. Phase three is about “the implementation of new evidence-based initiatives. This step involves role modeling and teaching new practices, making clear interdisciplinary expectations for use of newly adopted practices, determining the stability and reliability of new practices to ensure uniform use, and measuring outcome targets” (Melnyk, 2015).
I would apply the issue I am researching, the role of dipstick urinalysis in diagnosing urinary tract infections in older adults residing in health care facilities to phase three by implementing my findings into practice. The first step in this process would be to “educate clinicians and other stakeholders about new practice to be adopted” (Melnyk, 2015). In this case evidence shows that dipstick urinalysis alone should not be used to diagnosis urinary tract infections in the elderly. However, with symptoms present can be used as a diagnostic tool (Deville, 2004). Forthmore, urine dipstick assay can be used as a first level screening and can improve diagnostic accuracy (Deville, 2004).
The administration team would be a facilitator of using dipstick assays as screening/diagnostic procedure because it is cheap than a urinalysis and culture completed in a laboratory (Deville, 2004). In a similar manner, nurse would be a facilitator because dipstick assays are easily obtained in-patient with incontinent or foley catheters. They are also quicker that laboratory urinalysis, meaning nurse can request treatment for urinary tract infections sooner (Deville, 2004). While on the same hand, physician would be facilitator because a urine dipstick assay gives the physician more objective evidence to look at and see the whole picture (Deville,